Neuroleptic malignant syndrome (NMS) is a rare but potentially lethal outcome caused by sudden discontinuation or dose reduction of dopaminergic agents. We report an extremely rare case of NMS after deep brain stimulation (DBS) surgery in a cerebral palsy (CP) patient without the withdrawal of dopaminergic agents. A 19-year-old girl with CP was admitted for DBS due to medically refractory dystonia and rigidity. Dopaminergic agents were not stopped preoperatively. DBS was performed uneventfully under monitored anesthesia. Dopaminergic medication was continued during the postoperative period. She manifested spasticity and muscle rigidity, and was high fever resistant to anti-pyretic drugs at 2 h postoperative. At postoperative 20 h, she suffered cardiac arrest and expired, despite vigorous cardiopulmonary resuscitation. NMS should be considered for hyperthermia and severe spasticity in CP patients after DBS surgery, irrespective of continued dopaminergic medication.
■ Case Report ■ Cerebral palsy (CP) is marked by motor disturbances along with abnormal movements and postures that result from damage to the developing brain. [1] Management of severe dystonia in children with congenital CP is usually difficult. Treatment options include physical modalities, dopaminergic drugs, anti-cholinergic drugs or botulinum toxin muscle relaxants. [2, 3] Deep brain stimulation (DBS) has been found to be safe and effective in young patients with dystonia and spasticity of CP. [1, 4] In DBS, those drugs are transiently stopped prior to the procedure for intraoperative microelectrode recording (MER). Neuroleptic malignant syndrome (NMS) is a rare but potentially lethally morbid, with a mortality rate between 10% and 50%. [5] It is marked by high fever, severe rigidity, autonomic instability, and an altered level of consciousness. [5, 6] NMS can be caused by a sudden discontinuation or dose reduction of dopaminergic agents. [5] [6] [7] However, there is no report regarding a case showing NMS, despite scheduled medication of a dopaminergic agent without its dose reduction during the perioperative period.
Herein, we report an extremely rare case of NMS after DBS surgery in a CP patient without a dose reduction of dopaminergic agents.
Case Report
A 19-year-old girl with history of CP was scheduled for DBS of the globus pallidus pars internus (GPi) bilaterally due to medically refractory dystonia and rigidity . Her medication cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. (Table 1) . However, on postoperative 2 h, she manifested spasticity and muscle rigidity and took her medications, such as levodopa to relieve these symptoms. At that time, she had a high fever (40.6℃) resistant to anti-pyretic drugs (propacetamol 1 g). We suspected that hyperthermia was caused by postoperative atelectasis, but chest X-ray showed no significant abnormality except postoperative ileus (Fig. 2) . On postoperative 16 h, her general condition worsened convulsively despite aggres- sive care. She developed severe rigidity, tachycardia (heart rate: 170 beats/min), hyperventilation (respiration rate: 30 frequencies/min), and agitation. Her temperature had risen to 42°C, which was refractory to copious cooling treatment such as surface tepid massage, and her blood pressure had increased to 149/77 mmHg (Fig. 3 ).
On postoperative 20 h, she fell rapidly into a coma and showed bilateral pupil fixation (Glasgow Coma Scale: 3). and associated symptoms and signs (elevation of CK level, tachycardia, and altered mental status), which are listed in the Diagnostic and Statistical Manual of Mental Disorders.
Fig. 3.
A schematic illustration of changes in body temperature and the management of hyperthermia during the perioperative period. BT: body temperature; BP: blood pressure; HR: heart rate; RR: raspiration rate; R-ward: recovery ward; CPR: cardiopulmonary resuscitation; ICU: intensive care unit. in cases with dystonic symptoms related to CP. [11] In these days, DBS has been used as a major therapeutic modality for movement disorders, such as PD, essential tremor and dystonia. [12, 13] In particlar, DBS in GPi has been reported to be significantly useful in patients with dystonia. [14] Vidalihet et al. [1] showed that bilateral DBS also resulted in the improvement of motor symptoms and functional disability in CP patients with dystonia over a year.
The standard procedure of DBS is to use local anesthesia for intraoperative MER. This method allows intraoperative evaluation of the stimulation-induced improvement.
[15] Thus, discontinuation of dopaminergic medication is, in clinical practice, common prior to DBS surgery, which can induce NMS in a previous study. [16] In our study, we There are some diseases showing clinical manifestations similar with NMS. We can easily distinguish NMS from malignant hyperthermia because of different triggering agents.
Succinylcholine and inhalation agents are triggering agents for malignant hyperthermia while neuroleptic agents for NMS. Status epilepticus rarely causes high fever. Encephalitis also causes an elevation in body temperature, but the peak value of fever is lower in encephalitis than in NMS.
Moreover, rhabdomyolysis is rarely shown in encephalitis.
[ 18, 19] In conclusion, clinicians should consider NMS as a differential diagnosis when high fever refractory to conventional treatments, spasticity, and severe rigidity following the DBS surgery are manifested in a CP patient, who take dopaminergic medication on schedule time during the perioperative period. Early diagnosis and rapid aggressive management for NMS should be needed to prevent the regrettable result.
